Identifying cancer drug regimens in French health insurance database: An application in multiple myeloma patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Identifying cancer drug regimens in French health insurance database: An application in multiple myeloma patients

Published:2017-07-25 Issue:12 Volume:26 Page:1492-1499
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Palmaro Aurore¹²³^ORCID,Gauthier Martin⁴,Despas Fabien¹²³,Lapeyre-Mestre Maryse¹²³^ORCID

Affiliation:

1. Medical and Clinical Pharmacology Unit; CHU Toulouse University Hospital; Toulouse France

2. Pharmacoepidemiology Research Unit, INSERM 1027; University of Toulouse; Toulouse France

3. CIC 1436, Toulouse University Hospital; Toulouse France

4. Department of Haematology; Toulouse University Hospital; Toulouse France

Funder

Agence Nationale de la Recherche

La ligue contre le Cancer

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Reference25 articles.

1. French health insurance databases: what interest for medical research?;Moulis;Rev Med Interne,2014

2. Overview of drug data within French health insurance databases and implications for pharmacoepidemiological studies;Palmaro;Fundam Clin Pharmacol,2016

3. Temporal representation of care trajectories of cancer patients using data from a regional information system: an application in breast cancer;Defossez;BMC Med Inform Decis Mak,2014

4. Utility of the SEER-Medicare data to identify chemotherapy use;Warren;Med Care,2002

5. Construct validity of medicare chemotherapy claims: the case of 5FU;Lamont;Med Care,2002

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Survival outcomes for patients with multiple myeloma in France: A retrospective cohort study using the Système National des Données de Santé national healthcare database;European Journal of Haematology;2023-05-18

2. Real-world treatment response in Japanese patients with cancer using unstructured data from electronic health records;Health and Technology;2023-02-16

3. Usability of German hospital administrative claims data for healthcare research: General assessment and use case of multiple myeloma in Munich university hospital in 2015–2017;PLOS ONE;2022-07-28

4. Assessing the treatment pattern, health care resource utilisation, and economic burden of multiple myeloma in France using the Système National des Données de Santé (SNDS) database: a retrospective cohort study;The European Journal of Health Economics;2022-05-25

5. Identifying Valid Algorithms for Number of Lines of Anti-Neoplastic Therapy in the Danish National Patient Registry Among Patients with Advanced Ovarian, Gastric, Renal Cell, Urothelial, and Non-Small Cell Lung Cancer Attending a Danish University Hospital;Clinical Epidemiology;2022-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3